Semax and selank inhibit the enkephalin-degrading enzymes of human serum

Bioorganicheskaya Khimiya

Volumn 27, Issue 3, 2001, Pages 183-

  Kost, N V ^a   Sokolov, O Yu ^a   Gabaeva, M V ^a   Grivennikov, I A ^b   Andreeva, L A ^b   Myasoedov, N F ^b   Zozulya, A A ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^b INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

Author keywords

Enkephalinases, inhibitors; Opioid system; Regulatory peptides; Selank; Semax

Indexed keywords

EID: 0039563404     PISSN: 01323423     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ashmarin LP., Nezavibatko V.N., Levitskaya N.G., Koshelev V.N., Kamensky A.A. // Neurosci. Res. Communs. 1995. V. 16. P. 105-112.
2. Zagon I.S., Goodman S.R., McLaughlin P.J. // Brain Res. 1989. V. 482. P. 297-305.
3. Shen Y., Li R. // Med.Hypotheses. 1995. V. 45. P.529-538.
4. Marini M., Roscetti G., Bonjiorno L., Urbani A., Rodo L. // Neurochem. Res. 1990. V. 15. P. 61-67.
5. Potaman V.N., Alfeeva L.Y., Kamensky A.A., Nezavibatko V.N. // Peptides. 1993. V. 14. P. 491.
6. Zolotarev Yu.A., Dorokhova E.M., Nezavibatko V.N., Borisov Yu.A., Rosenberg S.G., Myasoedov N.F. // Amino Acids. 1995. V. 47. P. 353-365.